Healthtech startup 4baseCare has successfully raised an additional ₹38 crore (nearly $4 million) to close its Series B funding round at ₹128 crore ($13 million). This latest investment was led by growX Ventures, with participation from undisclosed existing investors.The company plans to utilize the newly acquired funds to expand its genomics laboratory network across India, the Middle East, Southeast Asia, Latin America, and Central Asia.Additionally, a portion of the capital will be allocated to scaling its AI-driven precision oncology platform, OncoTwin. Co-founder and CEO Hitesh Goswami stated that the additional capital will enhance their ability to provide clinicians with deeper, real-world, clinically actionable insights.Founded in 2018 by Goswami and Kshitij Rishi, 4baseCare employs advanced genomics, bioinformatics, and AI to deliver personalized oncology care. The startup also develops databases that integrate genomic data with clinical, environmental, and lifestyle information to improve precision medicine.This funding round follows a previous raise of ₹90 crore in the same Series B round, co-led by investors Ashish Kacholia and Lashit Sanghvi. Earlier, the Bengaluru-based startup had raised ₹50 crore in a Series A round led by Yali Capital in 2024.The healthtech sector in India continues to attract investor interest, particularly as many companies pivot towards longevity, prevention, and continuous health optimization, fueled by advancements in AI.Recent funding activity in the sector includes StrainX Bioworks raising $13 million and Practo co-founder Shashank ND’s new venture, Cent, securing $5 million in a seed round. According to Inc42 data, the Indian healthtech market is projected to reach a valuation of $37 billion by 2030.
